NEW YORK (GenomeWeb) – Genomic Health reported after the close of the market Tuesday that its third quarter revenues increased 6 percent year over year, driven by a 17 percent jump in tests delivered in the quarter.

The Redwood City, California-based molecular diagnostics firm reported total revenues of $73.6 million for the three months ended Sept. 30 compared to $69.1 million for the third quarter of 2014. It beat analysts' consensus estimate of $73.1 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.